非他汀类-话题@MedSci

#非他汀类#

4篇内容 | 348人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1819153, encodeId=0ed7181915383, content=<a href='/topic/show?id=2e0d9925549' target=_blank style='color:#2F92EE;'>#非他汀类#</a>, objectTitle=Esperion的非他汀类口服片剂NILEMDO，获欧洲批准治疗高胆固醇血症和混合性血脂异常, objectType=article, longId=191678, objectId=efac1916e828, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=efac1916e828, replyNumber=0, likeNumber=39, createdTime=2020-05-31, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=efac1916e828, moduleTitle=Esperion的非他汀类口服片剂NILEMDO，获欧洲批准治疗高胆固醇血症和混合性血脂异常, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=efac1916e828)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819152, encodeId=249018191520f, content=<a href='/topic/show?id=2e0d9925549' target=_blank style='color:#2F92EE;'>#非他汀类#</a>, objectTitle=Eur Heart J：二级预防他汀和非他汀类降LDL药对心血管结局有何影响？, objectType=article, longId=142637, objectId=40fa14263e8b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=40fa14263e8b, replyNumber=0, likeNumber=41, createdTime=2018-07-07, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=40fa14263e8b, moduleTitle=Eur Heart J：二级预防他汀和非他汀类降LDL药对心血管结局有何影响？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=40fa14263e8b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819151, encodeId=f1351819151ac, content=<a href='/topic/show?id=2e0d9925549' target=_blank style='color:#2F92EE;'>#非他汀类#</a>, objectTitle=JAHA：他汀类联合非他汀类药物能进一步改善冠心病患者预后, objectType=article, longId=121478, objectId=7a681214e8e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a681214e8e0, replyNumber=0, likeNumber=48, createdTime=2017-12-31, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a681214e8e0, moduleTitle=JAHA：他汀类联合非他汀类药物能进一步改善冠心病患者预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a681214e8e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819150, encodeId=4f09181915085, content=<a href='/topic/show?id=2e0d9925549' target=_blank style='color:#2F92EE;'>#非他汀类#</a>, objectTitle=Eur Heart J：他汀类药物和非他汀类降脂药物在二级预防中对心血管结局的影响：随机试验的荟萃分析。, objectType=article, longId=118724, objectId=f574118e24c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f574118e24c8, replyNumber=0, likeNumber=39, createdTime=2017-12-09, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f574118e24c8, moduleTitle=Eur Heart J：他汀类药物和非他汀类降脂药物在二级预防中对心血管结局的影响：随机试验的荟萃分析。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f574118e24c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

非他汀类

2020-05-29

liuhuangbo (审核中...)

前往app查看评论内容

#非他汀类#

Esperion的非他汀类口服片剂NILEMDO，获欧洲批准治疗高胆固醇血症和混合性血脂异常

2020-05-31

liuhuangbo (审核中...)

前往app查看评论内容

#非他汀类#

Eur Heart J：二级预防他汀和非他汀类降LDL药对心血管结局有何影响？

2018-07-07

liuhuangbo (审核中...)

前往app查看评论内容

#非他汀类#

JAHA：他汀类联合非他汀类药物能进一步改善冠心病患者预后

2017-12-31

liuhuangbo (审核中...)

前往app查看评论内容

#非他汀类#

Eur Heart J：他汀类药物和非他汀类降脂药物在二级预防中对心血管结局的影响：随机试验的荟萃分析。

2017-12-09

科室
- - 订阅+
  - 更多科室
工具
服务